Togo vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Togo
100.0%
in 2024
Western Pacific (WHO region)
86.0%
in 2024
Togo rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Togo
- Western Pacific (WHO region)
How they compare
Togo currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Togo's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 10 times across 17 shared years of data; in 2007 it was Togo ahead.
Togo ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Togo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Togo | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.6% | 1.3% | 11.4% | Togo |
| 2010s | 61.3% | 60.7% | 0.6% | Togo |
| 2020s | 92.2% | 89.2% | 3.0% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Togo or Western Pacific (WHO region)?
- Togo, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Togo and Western Pacific (WHO region)?
- 14.0%, with Togo ahead.
- How many years of comparable data are there for Togo and Western Pacific (WHO region)?
- 17 years are reported by both, from 2007 to 2024.
- How do Togo and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Togo ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.